YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway

Hun Kung Hsu, Shu Hui Juan, Pei Yin Ho, Yu Chih Liang, Chien-Huang Lin, Che Ming Teng, Wen Sen Lee

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

This study was designed to investigate the effect of YC-1, 3-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole, in human umbilical vein endothelial cells (HUVECs) proliferation and its underlying mechanism. YC-1 at a range of concentrations (5-50μM) inhibited DNA synthesis and decreased cell number in cultured HUVEC in a dose- and time-dependent manner. YC-1 was not cytotoxic at these concentrations. [3H]thymidine incorporation and flow cytometry analyses revealed that YC-1 treatment decreased DNA synthesis and arrested the cells at the G0/G1 phase of the cell cycle. Western blot analysis demonstrated that YC-1 (5-50μM) increased the levels of cyclin-dependent kinase (CDK)-inhibitory proteins (CKIs), p21 and p27, but did not induce any significant changes of cyclins and CDKs. In the YC-1-treated HUVEC, the formation of CDK2-p21 complex, but not CDK2-p27 complex, was increased and the assayable CDK2 kinase activity was decreased. These changes were in a dose-dependent manner. In contrast, the formations of CDK4-p21 and CDK4-p27 complex were slightly increased and the assayable CDK4 kinase activity was slightly decreased (if there were any changes). Pretreatment with guanylyl cyclase inhibitors, 1H-(1,2,4)oxadiazolo[4,3-a]quinozalin-1-one (ODQ) and methylene blue, inhibited the YC-1-induced increase of cyclic GMP level, but did not change significantly the magnitude of the YC-1-induced inhibition of thymidine incorporation and cell number in HUVEC. These results indicate that YC-1-induced cell cycle arrest in HUVEC occurred when the cyclin-CDK system was inhibited just as p21 and p27 protein levels were augmented. This YC-1-induced antiproliferation effect in HUVEC is via a cyclic GMP-independent pathway.

Original languageEnglish
Pages (from-to)263-271
Number of pages9
JournalBiochemical Pharmacology
Volume66
Issue number2
DOIs
Publication statusPublished - Jul 15 2003

Keywords

  • Cyclic GMP
  • Cyclin
  • Endothelial cells
  • p21
  • p27
  • YC-1

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway'. Together they form a unique fingerprint.

  • Cite this